Sleep deprivation in mood disorders

Research output: Contribution to journalArticlepeer-review

Abstract

Growing clinical evidence in support of the efficacy and safety of sleep deprivation (SD), and its biological mechanisms of action suggest that this technique can now be included among the first-line antidepressant treatment strategies for mood disorders. SD targets the broadly defined depressive syndrome, and can be administered according to several different treatment schedules: total versus partial, single versus repeated, alone or combined with antidepressant drugs, mood stabilizers, or other chronotherapeutic techniques, such as light therapy and sleep phase advance. The present review focuses on clinical evidence about the place of SD in therapy, its indications, dosage and timing of the therapeutic wake, interactions with other treatments, precautions and contraindications, adverse reactions, mechanism of action, and comparative efficacy, with the aim of providing the clinical psychiatrist with an updated, concise guide to its application.

Original languageEnglish
Pages (from-to)141-151
Number of pages11
JournalNeuropsychobiology
Volume64
Issue number3
DOIs
Publication statusPublished - Jul 2011

Keywords

  • Antidepressant
  • Bipolar disorder
  • Light therapy
  • Major depression
  • Mania
  • Sleep deprivation

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Neuropsychology and Physiological Psychology
  • Biological Psychiatry

Fingerprint Dive into the research topics of 'Sleep deprivation in mood disorders'. Together they form a unique fingerprint.

Cite this